Insider Transactions in Q4 2024 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,343
-0.72%
|
$243,831
$17.15 P/Share
|
|
Dec 31
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
1,854
-0.42%
|
$31,518
$17.15 P/Share
|
|
Nov 27
2024
|
Steve Elms |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,000
+0.42%
|
$90,000
$10.8 P/Share
|
|
Nov 22
2024
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
48,967
-2.4%
|
$1,028,307
$21.1 P/Share
|
|
Nov 22
2024
|
Brad L. Tade CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
15,000
-7.0%
|
$315,000
$21.15 P/Share
|